Estrella Immunopharma gets Nasdaq notice after ESLA bid price stays below $1 for 30 days
ESLA•Compliance deadline and next steps
The stock will keep trading on the Nasdaq Capital Market under ESLA, pending a cure by Feb. 16, 2027.
Compliance requires a $1 bid for at least 10 consecutive business days; Nasdaq can require up to 20.
Failure to regain compliance could trigger delisting proceedings; a reverse stock split remains an option.
Nasdaq notice for minimum bid price rule
Estrella Immunopharma received a Nasdaq notice on Aug. 17, 2026 for failing the $1 minimum bid rule.
Shares traded below $1 for 30 straight business days from July 6, 2026 through Aug. 14, 2026.
